Donor feline Serum - 100mL from Biomeda Corporation
Monocyte Activation Kit from 3H Biomedical AB
Goat Anti-NPT1 (M-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Suction Cups and Assemblies from Parker Hannifin Corporation
Biology Products:(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Fi...today announced the approval of all of its,"first ...District of Delaware,(the "Bankruptcy Court"). deC...f under Chapter 11 of the United States Bankruptcy...ders issued by the Bankruptcy Court allow the comp...
(Date:11/24/2009)...GHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolax...nistration (SFDA) has approved the,investigational...roject,(Nodlin), an innovative insulin formulation...xy to initiate its first phase I clinical study. ,... high blood glucose and poor,metabolism. The compl...
(Date:11/24/2009)... efficacy endpoint has been met for patients with ..., , QUEBEC CITY, Nov. 24 /PRNewswire-FirstCal...EZ) (the "Company"), a global biopharmaceutical co...oday announced positive efficacy data from a Phase...gate, AEZS-108 (formerly AN-152), in patients with...
(Date:11/24/2009)..., Nov. 24, 2009 Arena Ph...oday that the company is scheduled to present at t...e on December 1, 2009 at 11:30 a.m. Eastern Time (...el in New York City. Jack Lief, Arena,s President ...de an overview of the company, including its clini...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3